SANION.ST Stock - Saniona AB (publ)
Unlock GoAI Insights for SANION.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $334.67M | $16.84M | $15.28M | $10.48M | $8.20M |
| Gross Profit | $329.58M | $11.78M | $10.81M | $5.85M | $4.95M |
| Gross Margin | 98.5% | 70.0% | 70.7% | 55.8% | 60.3% |
| Operating Income | $241.88M | $-81,065,000 | $-225,719,000 | $-411,570,000 | $-159,375,000 |
| Net Income | $188.71M | $-95,810,000 | $-245,357,000 | $-410,898,000 | $-73,430,000 |
| Net Margin | 56.4% | -568.9% | -1605.4% | -3921.5% | -895.7% |
| EPS | $1.77 | $-1.49 | $-3.33 | $-5.57 | $-1.52 |
Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which is in Phase 1 clinical stage for rare neuropathic disorders; SAN903 that is in preclinical stage for rare inflammatory, fibrotic, and hematological disorders. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.
Visit WebsiteEarnings History & Surprises
SANION.STEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 26, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | — | — | — | — |
Q4 2025 | Nov 27, 2025 | — | — | — | — |
Q3 2025 | Aug 28, 2025 | — | $-0.17 | — | — |
Q2 2025 | May 28, 2025 | — | $0.16 | — | — |
Q1 2025 | Feb 27, 2025 | — | $2.17 | — | — |
Q4 2024 | Nov 28, 2024 | — | $-0.26 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.18 | — | — |
Q2 2024 | May 29, 2024 | — | $-0.10 | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.38 | — | — |
Q4 2023 | Nov 30, 2023 | — | $-0.32 | — | — |
Q3 2023 | Aug 31, 2023 | — | $-0.29 | — | — |
Q2 2023 | May 25, 2023 | — | $-0.29 | — | — |
Q1 2023 | Feb 23, 2023 | — | $-0.56 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.28 | — | — |
Q3 2022 | Aug 25, 2022 | — | $-1.42 | — | — |
Q2 2022 | May 25, 2022 | — | $-2.14 | — | — |
Q1 2022 | Feb 24, 2022 | — | $-2.08 | — | — |
Q4 2021 | Nov 18, 2021 | — | $-1.66 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-1.59 | — | — |
Latest News
Frequently Asked Questions about SANION.ST
What is SANION.ST's current stock price?
What is the analyst price target for SANION.ST?
What sector is Saniona AB (publ) in?
What is SANION.ST's market cap?
Does SANION.ST pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SANION.ST for comparison